BC
TNDM icon

Brookfield Corp’s Tandem Diabetes Care TNDM Stock Holding History

Brookfield Corp’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-56,816
Closed -$2.31M – 751
2023
Q1 		$2.31M Buy
56,816
+22,595
+66% +$935K 0.01% 407
2022
Q4 		$1.54M Sell
34,221
-19,939
-37% -$903K 0.01% 449
2022
Q3 		$2.59M Buy
+54,160
New +$2.97M 0.01% 400
2022
Q2 		– Sell
-9,697
Closed -$1.13M – 753
2022
Q1 		$1.13M Buy
9,697
+3,972
+69% +$464K ﹤0.01% 483
2021
Q4 		$862K Buy
+5,725
New +$773K ﹤0.01% 480

Other funds holding TNDM

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return